Skip to main content
. 2019 Mar 4;10(3):217. doi: 10.1038/s41419-019-1467-7

Fig. 1. NPTX2 expression is upregulated in CRC tissues and correlated with patient prognosis.

Fig. 1

a The mRNA expression of NPTX2 in CRC and adjacent noncancerous tissues, as analyzed from TCGA dataset (Student’s t test). b The mRNA expression of NPTX2 in CRC and adjacent noncancerous tissues, as analyzed from GEO dataset (Student’s t test). c Overall survival analysis based on the mRNA expression of NPTX2 from TCGA dataset (Kaplan–Meier method and log-rank test). d, e The protein expression of NPTX2 in normal, CRC, and liver metastasis tissues in tissue microarray (392 cases of normal tissues, 392 matched cases of CRC tissues, and 30 cases of liver metastasis) (Spearman’s rank correlation). f, g NPTX2 protein expression at different pathological stages in CRC tissues from tissue microarray (34 cases of stage I, 150 cases of stage II, 127 cases of stage III, and 81 cases of stage IV CRC) (Spearman’s rank correlation). h Overall survival analysis of the protein expression of NPTX2 based on the prognostic information of patients with CRC from tissue microarray data (Kaplan–Meier method and log-rank test). Measurement data were presented as the mean ± SD. *P < 0.05; *** P < 0.0001